Severity of liver disease and risk of cardiovascular events and mortality in people with non-alcoholic fatty liver disease and Type 2 diabetes

被引：0
|
作者：
Wild, S. H. [1 ]
Byrne, C. D. [2 ]
机构：
[1] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland
[2] Univ Southampton, Human Dev & Hlth, Fac Med, Southampton, Hants, England
来源：
DIABETIC MEDICINE | 2019年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A36
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [21] Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients
    Tsai, Hui-Ju
    Tsai, Yi-Chun
    Hung, Wei-Wen
    Hung, Wei-Chun
    Chang, Chen-Chia
    Dai, Chia-Yen
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (03):
  • [22] Non-alcoholic fatty liver disease severity and gut microbiota in type 2 diabetes patients
    Dai, C. Y.
    Tsai, Y. C.
    Hung, W. W.
    Hung, W. C.
    Chang, C. C.
    Tsai, H. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 94 - 94
  • [23] Non-alcoholic fatty liver disease and cardiovascular risk: an update
    Mullish, Benjamin H.
    Forlano, Roberta
    Manousou, Pinelopi
    Mikhailidis, Dimitri P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (12) : 1175 - 1177
  • [24] Cardiovascular Risk Factors in Non-Alcoholic Fatty Liver Disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Hultcrantz, Rolf W.
    Kechagias, Stergios
    HEPATOLOGY, 2018, 68 : 950A - 950A
  • [25] Cardiovascular risk factors in non-alcoholic fatty liver disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Askling, Johan
    Hultcrantz, Rolf
    Kechagias, Stergios
    LIVER INTERNATIONAL, 2019, 39 (01) : 197 - 204
  • [26] The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver disease
    Nasr, Patrik
    Fredrikson, Mats
    Ekstedt, Mattias
    Kechagias, Stergios
    LIVER INTERNATIONAL, 2020, 40 (05) : 1069 - 1078
  • [27] Non-alcoholic fatty liver disease and type 1 diabetes
    Moreno-Ruiz, I.
    Martin-Timon, I.
    Modamio-Molina, J.
    Bacete-Cebrian, S.
    Zubillaga-Gomez, M.
    Zeng, L.
    Meizoso-Pita, O.
    Trivino-Yannuzzi, V.
    Huguet-Moreno, I.
    Llavero-Valero, M.
    Lara-Moreno, C.
    Sevillano-Collantes, C.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S408 - S408
  • [28] Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes
    Zeinab Montazeri
    Nahid Hashemi-Madani
    Hamed Iraji
    Masoudreza Sohrabi
    Fariba Alaei-Shahmiri
    Zahra Emami
    Mohammad Reza Babaei
    Mojtaba Malek
    Mohammad E. Khamseh
    BMC Endocrine Disorders, 23
  • [29] Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes
    Montazeri, Zeinab
    Hashemi-Madani, Nahid
    Iraji, Hamed
    Sohrabi, Masoudreza
    Alaei-Shahmiri, Fariba
    Emami, Zahra
    Babaei, Mohammad Reza
    Malek, Mojtaba
    Khamseh, Mohammad E.
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [30] Non-alcoholic fatty liver disease and type 2 diabetes are mutually independent predictors of major cardiovascular events in patients with established cardiovascular disease
    Sprenger, Lukas
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 260 - 260
12345